Case series of 331 cases of sugammadex compared to neostigmine in patients under 2 years of age.

Amber M Franz Jennifer L Chiem Lizabeth D MartinSally RampersadJennifer PhillipsEliot B Grigg

Published in: Paediatric anaesthesia (2019)

Sugammadex administration in this young population did not result in any adverse effects. It appears to be equally effective as neostigmine in patients under 2 years of age.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis